GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024

WGSWW 10.03.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-10-29
Name of Upcoming Event:GeneDx Investor Relations Conference Call
Full Press ReleaseSEC FilingsOur WGSWW Tweets

About Gravity Analytica

Recent News

  • 01.17.2025 - GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 01.16.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.13.2025 - GeneDx Announces Preliminary 2024 Financial Results

Recent Filings

  • 01.16.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.13.2025 - 3 Initial statement of beneficial ownership of securities
  • 01.13.2025 - EX-99.1 EX-99.1
PDF Version

GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024

STAMFORD, Conn.--(BUSINESS WIRE)--Oct. 3, 2024--GeneDx(Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the third quarter of 2024 before the market opens onTuesday, October 29, 2024. Management will host a conference call that day to discuss third quarter 2024 financial and operating results at8:30 a.m. Eastern Time.

Conference Call Details

Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the “Events” section of theGeneDxinvestor relations website athttps://ir.genedx.com/.

AboutGeneDx

AtGeneDx(Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visitgenedx.comand connect with us onLinkedIn,X,Facebook, andInstagram.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241003803932/en/

Investor Relations Contact:investors@GeneDx.com

Media Contact:press@GeneDx.com

Source:GeneDx

PDF Version
Subscribe to Alerts
Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com